TORONTO, Dec. 11, 2013 /CNW/ - EMO CAPITAL CORP (NUVI:OTCBB) - is pleased to announce the finalization of key ingredients to formulate the RED XL, which is our flagship natural male enhancement pill. RED XL utilizes a unique blend of all natural products to deliver increased sexual performance!!!
Erectile dysfunction is known to be a highly common problem among men. Statistics reveal that almost 20 million men over the age of 20 suffer with some kind of erectile problems just in the US alone. Global figures are believed to be much higher.
RED XL works by increasing blood capacity of the penis tissue and also by stimulating cell growth within the parts of the penis known as corpora cavernosa. These 2 actions result in noticeably stronger erections, and some increase in length and girth of the penis.
ME4Free Red XL is a once-daily capsule for men that delivers a natural and effective method to maximize their sexual health by boosting testosterone levels. ME4Free male enhancement pills are preferred by users looking for an alternative to prescription pills.
The statements by our officers, and other statements regarding optimism related to the business, expanding exploration and development activities and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many risk factors that affect the industry the Company operates in and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
SOURCE: EMO CAPITAL CORP
For further information:
Telephone: 949 419 6588
Email: [email protected]